Wishful Thinking And The Fallacy Of Single-Subject Experimentation

Few elements in the public view of science and medicine rival the romantic image of a scientist drinking a self-concocted potion and risking his or her life to benefit humanity. Recently, K.S. Brown ( The Scientist, Dec. 11, 1995, page 1) outlined the history of self-experimentation in biomedical science. In but two paragraphs, however, was there any suggestion that, apart from being unconventional or potentially dangerous to researchers, self-experimentation as a methodological option might h

Written byMichal Jasie
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Experimenting on oneself is subject to an extreme form of the observer's effect, when the observer becomes the observed. Self-observation is not only, as philosophers of science put it, "theory-laden," but also heavily influenced by the subject's mood and yesterday's diet.

One might assert that self-experimentation represents only a minor current in research and as such poses little threat to the overall quality of biomedical science. However, self-experimentation is a special case of much more widespread research involving single subjects.

Single-subject studies, such as a widely publicized attempt to use baboon bone marrow for AIDS treatment involving a single patient, named Jeff Getty (see story on page 3), represent a seriously flawed scientific methodology. Consequently, the results of all single-subject studies are bound to be erroneous.

Do the errors matter? After all, every result obtained during the process of a scientific inquiry has an error attached to it, because the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies